Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million).
Sun Pharma's $11.75 billion Organon acquisition was much bigger than a typical pharma deal. Once people looked past the headline, the story became surprisingly interesting. The acquisition involved ...
SAO PAULO — A highly contested mining project in the Brazilian Amazon rainforest operated by Canadian company Belo Sun is expected to reach a key development Wednesday, when a Brazilian court will ...
Mr. Siegel, a professor of history at Boston University, recently wrote a book about the global history of painkillers. See more of our coverage in your search results.Encuentra más de nuestra ...
Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to ...
On April 26, 2026, Sun Pharmaceutical Industries Limited (“Sun Pharma”) and Organon & Co. (“Organon”) announced an agreement for Sun Pharma to acquire all outstanding shares of Organon in an all-cash ...
Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The closure is part of a $7.4 billion deal reached after Purdue and the ...
After surging 119.70% so far in April, Organon & Co. (NYSE:OGN) secures a spot on our list of the mid-cap stocks with the highest gains in April. On April 26, 2026, Sun Pharmaceutical Industries ...
India’s AZB & Partners and White & Case are advising Sun Pharmaceutical Industries Limited on its agreement to acquire Organon & Co., while Sullivan & Cromwell and Cyril Amarchand Mangaldas (CAM) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results